Clinical Trials Browser

Phase 3 × PRETEXT I Hepatoblastoma × Irinotecan × Clear all

NCT00980460 2026-03-19

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

Phase 3 Active not recruiting

236 enrolled 18 charts

Gastrointestinal

PRETEXT I Hepatoblastoma